Tagantiviral treatment

Hepatitis C In Drug And Alcohol Settings – National Course – Free Online Training

H

ASHM, July 2022 This free online training aims to provide participants with the knowledge and confidence to increase the management of HCV in alcohol and other drug settings. People who inject drugs represent approximately 90% of newly acquired hepatitis C (HCV) infections. This course aims to provide addiction physicians, general practitioners, nurse practitioners, and other practitioners...

Monkeypox Virus (MPV): Public Health Alert, Stigmatising Language Warning, and more

M

1. Monkeypox Virus (MPV) Infection Public Health Alert SA Health, 21 May 2022 Monkeypox infection is caused by monkeypox virus. It is endemic in central and west Africa with cases outside Africa usually detected in returned travellers. As of 20 May 2022, 15 countries have reported 27 confirmed and 45 suspected cases of monkeypox. Several countries have reported cases in men who have sex with men...

Online training: Hepatitis C in Primary Care

O

ASHM, August 2020 This training aims to provide participants with the knowledge and confidence to pursue the management of HCV in their primary care setting. Primary care providers can play a critical role in the elimination of hepatitis C in Australia by 2030. This workshop will provide an overview of the management of HCV in primary care settings, including case finding, testing, patient...

Nurse Practitioner (s100) Prescribing Change

N

Hepatitis Australia, 3 April 2020 Hepatitis Australia warmly welcomes recent changes to the Pharmaceutical Benefits Scheme (PBS) allowing authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Both hepatitis B and hepatitis C are under-treated and without improvement in a range of areas Australia risks falling short of...

Coronavirus disease (COVID-19), HIV & hepatitis C: What you need to know

C

CATIE (Canada), 17 March 2020 An HIV-positive person on effective treatment is not expected to be at higher risk of becoming seriously ill with COVID-19 A person with untreated HIV or a low CD4+ cell count may be at higher risk of becoming seriously ill with COVID-19 People with HIV or hepatitis C are more likely to have other conditions that carry a greater risk of becoming seriously ill with...

Striving towards the elimination of HCV infection among PWID

S

International Journal of Drug Policy, Volume 72,Pages 1-198 (October 2019) Nearly 200 pages of open access articles from projects and research around the world. While this special issue highlights some successful efforts towards HCV elimination among people who inject drugs, it also highlights the relative lack of attention to settings in which resources enabling elimination are scarce, and where...

Your sidebar area is currently empty. Hurry up and add some widgets.